Menu

Impact Events

More
Date Lead Company Event Type Approval Change Approval Likelihood
10/22/25 Ventyx Biosciences (VTYX) VTX-3232 for Obesity Subscribers Only Subscribers Only Subscribers Only
10/21/25 Terns Pharmaceuticals (TERN) TERN-601 for Obesity Subscribers Only Subscribers Only Subscribers Only
10/20/25 IO (IOBT) Cylembio for Melanoma Subscribers Only Subscribers Only Subscribers Only
10/20/25 Sanofi (SNY) AlphaMedix for Neuroendocrine Tumors (NET) Subscribers Only Subscribers Only Subscribers Only
10/20/25 Xcovery Ensacove for Non-Small Cell Lung Cancer (NSCLC) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected Date Range Lead Company Drug Expected Catalyst
01/31/2025 Subscribers Only Subscribers Only Trial Announcement - Initiation
01/31/2025 Subscribers Only Subscribers Only Trial Announcement - Initiation
06/25/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
06/25/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
06/26/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update